Research/art/teacher profile of a person
Name and surname:
doc. MUDr. Zuzana Čierna, PhD.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Čierna
I.2 - Name
Zuzana
I.3 - Degrees
doc. MUDr., PhD.
I.4 - Year of birth
1976
I.5 - Name of the workplace
Institute of Pathological Anatomy, Faculty of Medicine, Comenius University in Bratislava and University Hospital Bratislava
I.6 - Address of the workplace
Dekanát LF UK, Špitálska ulica 24, 813 72 Bratislava
I.7 - Position
assistant professor
I.8 - E-mail address
cierna1@uniba.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/3482
I.10 - Name of the study field in which a person works at the university
Pathological Anatomy and Forensic medicine
I.11 - ORCID iD
0000-0003-2081-379X

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.2 - Second degree of higher education
II.a - Name of the university or institution
Faculty of Medicine, Comenius University
II.b - Year
2001
II.c - Study field and programme
General medicine
II.3 - Third degree of higher education
II.a - Name of the university or institution
Faculty of Medicine, Comenius University
II.b - Year
2015
II.c - Study field and programme
Pathological Anatomy and Forensic medicine
II.4 - Associate professor
II.a - Name of the university or institution
Faculty of Medicine, Comenius University
II.b - Year
2019
II.c - Study field and programme
Pathological anatomy and Forensic medicine
II.5 - Professor
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
Assistant professor (2010-2019), associate professor (2019 - ) Department of Pathology, Faculty of Medicine, Comenius University and University hospital Bratislava 2010 up to now
Assistant professor (2018 - ) Department of Pathology, Faculty of Health Care and Social Work, Trnava University and Faculty hospital Trnava 2018 up to now
Scientific-research activity Medirex Group Academy 2014 - 2021
Medical doctor St. Elisabeth Cancer Institute Bratislava 2012 - 2014
Postgraduate student Department of Gynaecology and Obstetrics, Faculty of Medicine, Comenius University and Faculty Hospital, Bratislava 2002 - 2010

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other IV.b - Name of the institution IV.c - Year
Specialization in Pathological anatomy Faculty of Medicine, Comenius University 2017
Specialization in Healthcare Management and Financing Faculty of Medicine, Comenius University 2021

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.1.a - Name of the profile course V.1.b - Study programme V.1.c - Degree V.1.d - Field of study
Pathological anatomy 1 + 2 in slovak and english language General medicine I.+II. General medicine
Pathological anatomy 1 + 2 in slovak and english language Dentistry I.+II. Dentistry
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.a - Bachelor's (first degree)
4
V.4.b - Diploma (second degree)
6
V.4.c - Dissertation (third degree)
4
V.4.2 - Number of defended theses
V.4.a - Bachelor's (first degree)
0
V.4.b - Diploma (second degree)
11
V.4.c - Dissertation (third degree)
0
V.5 - Overview of other courses taught in the current academic year according to study programmes
V.5.a - Name of the course V.5.b - Study programme V.5.c - Degree V.5.d - Field of study
Surgical pathology General medicine I.+II. General medicine

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
110
VI.1.b - Over the last six years
21
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
58 Web of Science, 41 Scopus
VI.1.b - Over the last six years
12 Web of Science, 13 Scopus
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
815 Web of Science, 850 Scopus
VI.1.b - Over the last six years
563 Web of Science, 614 Scopus
VI.1.5 - Number of invited lectures at the international, national level
VI.2 - The most significant research/artistic/other outputs
1

Cierna, Z., Mego, M., Miskovska, V., Machalekova, K., Chovanec, M., Svetlovska, D., Hainova, K., Rejlekova, K., Macak, D., Spanik, S., Ondrus, D., Kajo, K., Mardiak, J., Babal, P. 2016. Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors. In: Ann Oncol. 2016, 27(2). 300-305. (IF = 11,855; Q1)

2

Chovanec, M., Cierna, Z., Miskovska, V., Machalekova, K., Kalavska, K., Rejlekova, K., Svetlovska, D., Macak, D., Spanik, S., Kajo, K., Babal, P., De Giorgi, U., Mego, M., Mardiak, J. 2018. Systemic immune-inflammation index in germ-cell tumours. In: Br J Cancer. 2018, 118(6). 831-838. (IF = 5,416; Q1)

3

Chovanec, M., Cierna, Z., Miskovska, V., Machalekova, K., Svetlovska, D., Kalavska, K., Rejlekova, K., Spanik, S., Kajo, K., Babal, P., Mardiak, J., Mego, M. 2017. Prognostic role of programmed-death ligand 1 (PD-L1) expressing tumor infiltrating lymphocytes in testicular germ cell tumors. In: Oncotarget. 2017, 8(13). 21794-21805. (Q1/Q2)

4

Cierna, Z., Mego, M., Janega, P., Karaba, M., Minarik, G., Benca, J., Sedlackova, T., Cingelova, S., Gronesova, P., Manasova, D., Pindak, D., Sufliarsky, J., Danihel, L., Reuben, J. M., Mardiak, J. 2014. Matrix metalloproteinase 1 and circulating tumor cells in early breast cancer. In: BMC Cancer. 2014, 14(1). 472. (IF = 3,362; Q2)

5

Mego, M., Cierna, Z., Svetlovska, D., Macak, D., Machalekova, K., Miskovska, V., Chovanec, M., Usakova, V., Obertova, J., Babal, P., Mardiak, J. 2013. PARP expression in germ cell tumours. In: J Clin Pathol. 2013, 66(7). 607-612. (IF = 2,551; Q2)

VI.3 - The most significant research/artistic/other outputs over the last six years
1

Cierna, Z., Miskovska, V.,Roska, J., Jurkovicova, D., Pulzova, LB., Sestakova, Z., Hurbanova, L., Machalekova, K., Chovanec, M., Rejlekova, K., Svetlovska, D., Kalavska, K., Kajo, K., Babal, P., Mardiak, J., Ward, TA., Mego, M., Chovanec, M. 2020. Increased levels of XPA might be the basis of cisplatin resistance in germ cell tumours. In: BMC Cancer. 2020, 20(1). (IF = 4,430, Q2)

2

Schmidtova, S., Kalavska, K., Gercakova, K., Cierna, Z., Miklikova, S., Smolkova, B., Buocikova, V., Miskovska, V., Durinikova, E., Burikova, M., Chovanec, M., Matuskova, M., Mego, M., Kucerova, L. 2019. Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells. In: Cancers. 2019, 11(9). (IF = 6,126; Q1)

3

Cierna, Z., Smolkova, B., Cholujova, D., Gronesova, P., Miklikova, S., Cihova, M., Plava, J., Mego, M. 2021. Decreased levels of circulating cytokines VEGF, TNF-β and IL-15 indicate PD-L1 overexpression in tumours of primary breast cancer patients. In: Sci Rep. 2021; 11(1). (IF = 4,996; Q2)

4

Smolkova, B., Cierna, Z., Kalavska, K., Miklikova, S., Plava, J., Minarik, G., Sedlackova, T., Cholujova, D., Gronesova, P., Cihova, M., Majerova, K., Karaba, M., Benca, J., Pindak, D., Mardiak, J., Mego, M. 2021. Increased Stromal Infiltrating Lymphocytes Are Associated with the Risk of Disease Progression in Mesenchymal Circulating Tumor Cell-Positive Primary Breast Cancer Patients. In: IJMS. 2021; 21(24). (IF = 5,6; Q1)

5

Kalavska, K., Cierna, Z., Karaba, M., Minarik, G., Benca, J., Sedlackova, T., Kolekova, D., Martonova, I., Mardiak, J., Mego, M., Pindak, D. 2021. Prognostic role of matrix metalloproteinase 9 in early breast cancer. In: Oncology Letters. 2021; 78. (IF = 2,9; Q2)

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

Genomic landscape of platinum resistant and sensitive testicular cancers. Macintyre, G.; Brenton, J.D.; O'Connor, S.

2

The developmental origin of cancers defines basic principles of cisplatin resistance. Murray, M.J.; Coleman, N.

3

Deep learning for detecting tumour-infiltrating lymphocytes in testicular germ cell tumours. Taylor, J.C.; Alveyn, E.; Verrill, C.

4

Personalized medicine: Stem cells in colorectal cancer treatment. Patsalias, A.

5

Clinical Response of a Patient to Anti-PD-1 Immunotherapy and the Immune Landscape of Testicular Germ Cell Tumors. Ward, J.E.; Bao, R.; Hall, C.R.; Brockstein, B.E.; Luke, J.J.; Shah, S.

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

Identification of new treatment options in refractory testicular germ cell tumors.

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

IX. - Other relevant facts

Date of last update
2024-05-05